Showing results (371-380 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|July 13, 2004
Functional polymorphisms of UDP-glucuronosyltransferases 1A1, 1A6 and 1A8 are not involved in chronic pancreatitisMariette Verlaan, René H M te Morsche, Akos Pap, et al.Pharmacogenetics|July 1, 2004
Identification of a novel variant CYP2C9 allele in ChineseDayong Si, Yingjie Guo, Yifan Zhang, et al.Pharmacogenetics|April 30, 2004
Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokineticsKatherine D Furman, David R Grimm, Toby Mueller, et al.Pharmacogenetics|April 30, 2004
Human controlled ovarian hyperstimulation outcome is a polygenic traitFrancisco de Castro, Francisco J Morón, Luis Montoro, et al.Pharmacogenetics|April 30, 2004
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levelsMichael V Mandola, Jan Stoehlmacher, Wu Zhang, et al.Pharmacogenetics|October 12, 2004
Extracting and characterizing gene-drug relationships from the literatureJeffrey T Chang, Russ B AltmanPharmacogenetics|October 12, 2004
Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-upAlessandro Serretti, Raffaella Zanardi, Linda Franchini, et al.Pharmacogenetics|September 30, 2004
Functional polymorphism of human glutathione transferase A3: effects on xenobiotic metabolism and steroid biosynthesisNatasha Tetlow, Marjorie Coggan, Marco G Casarotto, et al.Pharmacogenetics|September 30, 2004
Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis studyShaoyong Su, Jianhong Chen, Jiangong Zhao, et al.Pharmacogenetics|September 30, 2004
Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West AfricaLeszek Wojnowski, Paul C Turner, Bonnie Pedersen, et al.Pageof 83